Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1999
11/11/1999CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999CA2331041A1 Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine
11/11/1999CA2330388A1 Compounds having glucuronic acid derivative and glucosamine derivative in structure thereof, method for producing the compounds, and uses of the compounds
11/11/1999CA2328732A1 Biphenyl derivatives
11/11/1999CA2328476A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999CA2327526A1 Thrombolytic agents derived from streptokinase
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955309A1 Inhibitors and substrates of thrombin
11/10/1999EP0955299A1 Benzothiophene, benzofurane and indole derivatives, process for their preparation and pharmaceutical compositions containing them
11/10/1999EP0955056A1 Recombinant colony stimulating factor-1 for treatment of fungal infection
11/10/1999EP0955044A2 Method of inhibiting bacterial or fungal growth using a complexing agent
11/10/1999EP0954591A2 Mini-adenoviral vector
11/10/1999EP0954532A1 Novel human apoptosis regulator
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954306A1 Methods of increasing nitric oxide synthesis
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0773949B1 D-mannose or xylitol esters and their use as drugs
11/10/1999CN1234798A Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
11/10/1999CN1234792A Nitric ester derivatives and use in treatment of urinary incontinence and other diseases
11/10/1999CN1234791A Inhibition of matrix metalloproteases by 2-('omega'-aroylalkyl)-4-biaryl-oxobutyric acids
11/10/1999CN1234739A Crystalline pharmaceutical product
11/10/1999CN1234406A Single-chain multiple antigen-binding molecule, its preparation and use
11/10/1999CN1046292C Method of chemical dressing hemoglobins used as oxygen carrier in blood substitution material
11/10/1999CN1046277C Quinoline derivative, preparing method and use thereof
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981710 Therapeutic hemoglobin composition having isotropically increased size
11/09/1999US5981708 Rodent polypeptide which is an autocrine growth factor; for augmenting growth of hematopoeitic stem cells; for antitumor agents to control tumor cell growth
11/09/1999US5981697 Synthetic peptides, antibodies against them and their use
11/09/1999US5981568 Therapeutic inhibitor of vascular smooth muscle cells
11/09/1999US5981531 For inhibiting platelet aggregation
11/09/1999US5981525 Indole derivatives useful in the treatment of osteoporosis
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981492 Substituted 5-membered ring heterocycles, their preparation and their use
11/09/1999US5981490 Peptidyl compounds
11/09/1999US5981277 Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055866A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999WO1999055355A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999WO1999055350A1 Antithrombotic agents
11/04/1999WO1999055339A1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999055306A1 Pharmaceutical composition comprising factor viii and neutral liposomes
11/04/1999DE19819548A1 Biphenylderivate Biphenyl
11/04/1999CA2330013A1 An anti-thrombotic agent comprising tomato fruit extract
11/04/1999CA2329929A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
11/04/1999CA2326819A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/03/1999EP0952830A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
11/03/1999EP0754058B1 Wound healing
11/03/1999EP0401303B2 Novel human tissue plasminogen activator variants and processes
11/03/1999CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977313 Nondegraded active fibrinogen or fragments bound to insoluble carrier; anticarcinogenic/antitumor/antimetastasis agents to remove circulating metastatic tumour cells, or suppress deposition in vessels; treatment of thrombocytopenia
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
11/02/1999US5977064 Cyclic tetrapeptide as anticoagulant
11/02/1999US5977057 Administering tissue factor pathway inhbibitor
11/02/1999US5977056 Treatment of thrombotic events
11/02/1999US5976849 Human E3 ubiquitin protein ligase
11/02/1999US5976841 Proteins having fibrinolytic and coagulation--inhibiting properties
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976837 Secreted proteins and polynucleotides encoding them
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999US5976532 Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3
11/02/1999US5976530 Peptide plasminogen activators
10/1999
10/28/1999WO1999054486A1 Canine erythropoietin gene and recombinant protein
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999WO1999054313A1 Bicyclic compounds having an anti-thrombitic effect
10/28/1999WO1999054298A1 Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
10/28/1999WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999WO1999042089A9 Use of thiadiazolo[4,3-a]pyridine derivatives
10/28/1999CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999CA2326384A1 Canine erythropoietin gene and recombinant protein
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2323606A1 Bicyclic compounds having an anti-thrombitic effect
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0951542A2 Secreted proteins and polynucleotides encoding them
10/27/1999EP0951470A1 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
10/27/1999EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0533862B1 Recombinant human factor viii derivatives
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233247A Thio acid derived monocyclic N-heterocyclics as anticoagulants
10/27/1999CN1233176A Substituted tricyclics
10/27/1999CN1233169A Process for the manufacture of a pulverous preparation
10/26/1999US5973188 Anticoagulant; prevention cell, protein binding
10/26/1999US5973134 Rat CNP complementary DNA and precursor protein
10/26/1999US5973003 Treatment of thrombosis, stroke, myocardial infarction, inflammation and arteriosclerosis
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972947 Anticoagulant, cardiovascular disorders, antiinflammatory agents, osteoporosis, antitumor agent
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999US5972885 Method for treatment of hemophilia by extravascular administration of factor VIII deletion derivatives
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 671